Investegate |Advanced Oncotherapy Announcements | Advanced Oncotherapy: Investor / Analyst Event Update
Investegate announcements from Advanced Oncotherapy, Investor / Analyst Event Update
Stay updated with breaking news from Analyst Event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Advanced Oncotherapy, Investor / Analyst Event Update
Second quarter 2022 revenues of $4.7 billion; GAAP net income of $2.2 billion and GAAP diluted EPS of $5.24Company reiterates advance purchase agreements for expected delivery in 2022 of approximately
/PRNewswire/ -- The prestigious international publication Institutional Investor recognized Grupo Financiero Banorte as the "Most Honored Company" in Mexico in...
First quarter 2022 revenues of $6.1 billion; GAAP net-income of $3.7 billion and GAAP diluted EPS of $8.58Moderna reiterates its 2022 signed advance purchase agreements of approximately $21 billionCompany
Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29Moderna